Brandon Folkes
Stock Analyst at H.C. Wainwright
(3.56)
# 2,264
Out of 4,690 analysts
524
Total ratings
44.6%
Success rate
3.3%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGMT Sagimet Biosciences | Reiterated: Buy | $29 | $10.55 | +174.88% | 10 | Aug 26, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $26 | $11.57 | +124.82% | 15 | Aug 21, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.84 | +1,209.52% | 11 | Aug 21, 2026 | |
| TRAW Traws Pharma | Reiterated: Hold | $1 | $0.5899 | +69.52% | 5 | Aug 18, 2026 | |
| RNTX Rein Therapeutics | Reiterated: Buy | $8 | $0.7621 | +949.73% | 9 | Aug 18, 2026 | |
| HRTX Heron Therapeutics | Downgraded: Hold | n/a | $0.3266 | - | 40 | Aug 17, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 | $8.30 | +56.63% | 13 | Aug 14, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $12.52 | $2.70 | +363.65% | 14 | Aug 14, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $2.23 | +213.90% | 16 | Aug 14, 2026 | |
| VALN Valneva SE | Reiterated: Buy | $18 | $6.43 | +179.94% | 9 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $24.73 | +142.62% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.20 | +150.00% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $18.61 | +77.32% | 26 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.50 | +566.67% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.16 | +589.66% | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.07 | +156.41% | 11 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15.30 | $9.28 | +64.88% | 17 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.47 | +74.03% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $8.10 | +48.15% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.60 | +47.06% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $72.83 | +66.14% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $16.79 | +42.94% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $25.32 | +136.97% | 41 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $8.48 | +17.92% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.95 | +153.16% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $34.87 | +37.65% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $5.60 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $8.17 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $5.91 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $2.65 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $0.8849 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000016 | n/a | 2 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 → $33 | $0.925 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $15 | $2.63 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $245.86 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $40 | $0.661 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0005 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $50 | $0.001 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $47.41 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $51.47 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $244.54 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $34.57 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $19.21 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $37.67 | n/a | 2 | Sep 12, 2016 |
Sagimet Biosciences
Aug 26, 2026
Reiterated: Buy
Price Target: $29
Current: $10.55
Upside: +174.88%
Zevra Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $26
Current: $11.57
Upside: +124.82%
Rani Therapeutics Holdings
Aug 21, 2026
Reiterated: Buy
Price Target: $11
Current: $0.84
Upside: +1,209.52%
Traws Pharma
Aug 18, 2026
Reiterated: Hold
Price Target: $1
Current: $0.5899
Upside: +69.52%
Rein Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7621
Upside: +949.73%
Heron Therapeutics
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3266
Upside: -
CorMedix
Aug 14, 2026
Reiterated: Buy
Price Target: $13
Current: $8.30
Upside: +56.63%
Cardiol Therapeutics Inc.
Aug 14, 2026
Reiterated: Buy
Price Target: $12.52
Current: $2.70
Upside: +363.65%
Connect Biopharma Holdings
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $2.23
Upside: +213.90%
Valneva SE
Aug 14, 2026
Reiterated: Buy
Price Target: $18
Current: $6.43
Upside: +179.94%
Aug 14, 2026
Reiterated: Buy
Price Target: $60
Current: $24.73
Upside: +142.62%
Aug 13, 2026
Reiterated: Buy
Price Target: $3
Current: $1.20
Upside: +150.00%
Aug 13, 2026
Reiterated: Buy
Price Target: $33
Current: $18.61
Upside: +77.32%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.16
Upside: +589.66%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $5.07
Upside: +156.41%
Aug 13, 2026
Reiterated: Buy
Price Target: $15.30
Current: $9.28
Upside: +64.88%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $7.47
Upside: +74.03%
Aug 11, 2026
Reiterated: Buy
Price Target: $12
Current: $8.10
Upside: +48.15%
Aug 11, 2026
Reiterated: Buy
Price Target: $20
Current: $13.60
Upside: +47.06%
Aug 11, 2026
Reiterated: Buy
Price Target: $121
Current: $72.83
Upside: +66.14%
Aug 11, 2026
Maintained: Buy
Price Target: $24
Current: $16.79
Upside: +42.94%
Aug 7, 2026
Reiterated: Buy
Price Target: $60
Current: $25.32
Upside: +136.97%
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $8.48
Upside: +17.92%
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $3.95
Upside: +153.16%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $34.87
Upside: +37.65%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $5.60
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $8.17
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $5.91
Upside: n/a
May 3, 2024
Maintained: Buy
Price Target: $3 → $4
Current: $2.65
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $20 → $10
Current: $0.8849
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000016
Upside: n/a
Mar 13, 2023
Maintained: Hold
Price Target: $37 → $33
Current: $0.925
Upside: n/a
Feb 9, 2023
Maintained: Buy
Price Target: $22 → $15
Current: $2.63
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $245.86
Upside: n/a
Nov 22, 2022
Maintained: Buy
Price Target: $22 → $40
Current: $0.661
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0005
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $5 → $50
Current: $0.001
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $47.41
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $51.47
Upside: n/a
Oct 6, 2021
Maintained: Buy
Price Target: $210
Current: $244.54
Upside: n/a
Aug 9, 2021
Maintained: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $34.57
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $19.21
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $37.67
Upside: n/a